Sri Lanka, July 8 -- President Anura Kumara Dissanayake has affirmed that every possible step will be taken to ensure justice to the victims of the Easter Sunday attacks, without allowing the passage ... Read More
Mumbai, July 8 -- Omaxe announced a significant expansion in Madhya Pradesh with the acquisition of a 450-acre land parcel along the Super Corridor in Indore. Omaxe is set to develop a modern integrat... Read More
Jakarta, July 8 -- The Indonesian National Alms Agency (Baznas) estimates that public religious funds in mosques nationwide from almsgiving, voluntary charity, and donations (ZIS) could reach Rp6.56 t... Read More
New Delhi, July 8 -- The Haj Committee of India, under the Ministry of Minority Affairs, has officially opened the application process for Haj 2026, a sacred pilgrimage of profound importance for the ... Read More
Mumbai, July 8 -- Multi Commodity Exchange of Indiaannounced the launch of the Electricity Futures Contract, effective from Thursday, 10 July 2025, marking a significant milestone in the development o... Read More
Dimapur, July 8 -- Three relief camps have been set up at BSNL quarters in Walford, S.M. Colony, and Namgalong Colony for those affected in Nagaland's Dimapur. The Dimapur District Disaster Managemen... Read More
Sri Lanka, July 8 -- The first malaria treatment suitable for babies and very young children has been approved for use. It's expected to be rolled out in African countries within weeks. Until now th... Read More
Jakarta, July 8 -- The governments of Indonesia and the United States are still engaged in talks following the recent announcement of a 32-percent tariff on Indonesian products, Deputy Minister of Tra... Read More
Nigeria, July 8 -- The Kaduna State Government has begun a free bus service for civil servants, retirees, students, and security personnel in the state capital. The initiative, part of the Kaduna Sub... Read More
India, July 8 -- ProKidney Corp. (PROK) shares surged 496.87 percent to $3.62 on Tuesday after the company announced positive topline results from its Phase 2 REGEN-007 trial evaluating rilparencel, a... Read More